Author:
Bazzi Angela R.,Bordeu Michelle,Baumgartner Katrina,Sproesser Darien M.,Bositis Christopher M.,Krakower Douglas S.,Mimiaga Matthew J.,Biello Katie B.
Abstract
Abstract
Background
HIV incidence has recently increased among people who inject drugs (PWID) across the United States, with outbreaks occurring in states with long-standing syringe service programs (SSPs) including Massachusetts (MA). Antiretroviral pre-exposure prophylaxis (PrEP) is an evidence-based HIV prevention strategy recommended for PWID, but uptake in this marginalized population is extraordinarily low.
Methods
We describe the design and procedures for a National Institute on Drug Abuse (NIDA)-funded (R01) randomized controlled trial (RCT) testing the efficacy of “PrEP for Health,” a multicomponent behavioral intervention to increase PrEP uptake, adherence, and persistence among HIV-negative PWID attending SSPs in two areas of the U.S. Northeast that are heavily affected by injection-related HIV transmission. Participants are equally randomized to receive the “PrEP for Health” intervention (involving individually tailored HIV and PrEP education, motivational interviewing, problem-solving skills and planning, and ongoing navigation support) or an enhanced standard of care (eSOC) control condition involving a brief educational video on the utility of PrEP for HIV prevention. Co-primary outcomes are PrEP uptake (using medical/pharmacy records) and adherence (using tenofovir quantification in hair samples); a secondary outcome is PrEP persistence (using medical/pharmacy records) over 12 months. Major assessments occur at baseline, 1-, 3-, 6-, and 12-month follow-up visits. Planned analyses will examine intervention efficacy, specific hypothesized conceptual mediators of the intervention effect (e.g., self-perceived HIV risk; PrEP knowledge, interest in use, motivation, and behavioral skills) and epidemiologically linked moderators (e.g., age; gender; condomless vaginal or anal sex).
Discussion
Findings from our extensive preliminary research with the study population revealed that a multicomponent, theory-based intervention targeting PrEP knowledge, motivation, self-efficacy, behavioral skills, and structural barriers to PrEP access is urgently needed for PWID who are at risk of HIV acquisition. We also learned that SSPs represent a highly acceptable service setting for delivering such interventions. In this study, we are evaluating the efficacy of the “PrEP for Health” intervention. If efficacious, findings from our implementation evaluation could help guide its dissemination to diverse SSPs and possibly other community-based settings accessed by this population.
Trial registration
ClinicalTrials.gov number NCT04430257, registered June 12, 2020.
Funder
National Institute on Drug Abuse
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference89 articles.
1. Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA Mar. 2019;5(9):844–5. https://doi.org/10.1001/jama.2019.1343.
2. U.S. Centers for Disease Control and Prevention Health Alert Network. Recent HIV Clusters and Outbreaks Across the United States Among People Who Inject Drugs and Considerations During the COVID-19 Pandemic. 2020. Available at: https://emergency.cdc.gov/han/2020/han00436.asp; Accessed 17 Dec 2021
3. Broz D, Carnes N, Chapin-Bardales J, the U.S. Syringe Services Programs’ Role in Ending the HIV Epidemic in : Why We Cannot Do It Without Them. Am J Prev Med. Nov 2021;61(5 Suppl 1):S118-S129. doi:https://doi.org/10.1016/j.amepre.2021.05.044
4. Centers for Disease Control and Prevention. HIV Surveillance Report,. 2018 (Updated 2020); vol. 31. Avaialble at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed 26 May, 2021. 2020.
5. Alpren C, Dawson EL, John B, et al. Opioid use fueling HIV Transmission in an urban setting: an outbreak of HIV infection among people who inject Drugs-Massachusetts, 2015–2018. Am J Public Health Jan. 2020;110(1):37–44. https://doi.org/10.2105/AJPH.2019.305366.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献